Graf Akcie ENZ (Enzo Biochem, Inc.). Diskuze k akciím ENZ. Aktuální informace ENZ.

Základní informace o společnosti Enzo Biochem, Inc. (Akcie ENZ)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 172.56M
Hodnota podniku (EV) 138.93M
Tržby 117.731M
EBITDA 9.169M
Zisk 7.875M
Růst v tržbách Q/Q 27.07 %
Růst v tržbách Y/Y 54.87 %
P/E (Cena vůči ziskům) 24.19
Forward P/E N/A
EV/Sales 1.18
EV/EBITDA 15.15
EV/EBIT 17.89
PEG N/A
Price/Sales 1.47
P/FCF N/A
Price/Book 2.52
Účetní hodnota na akcii 1.54
Hotovost na akcii 0.98
FCF vůči ceně -2.35 %
Počet zaměstnanců 428
Tržba na zaměstnance 275.072k
Profit margin 6.69 %
Operating margin 0.59 %
Gross margin 45.51 %
EBIT margin 6.60 %
EBITDA margin 7.79 %
EPS - Zisk na akcii 0.16
EPS - Kvartální růst -883.33 %
EPS - Očekávaný růst příští rok N/A %
Return on assets 6.96 %
Return on equity 12.38 %
ROIC 6.96 %
ROCE 8.86 %
Dluhy/Equity 0.66
Čistý dluh/EBITDA -6.85
Current ratio 2.71
Quick Ratio 2.22
Volatilita 4.87
Beta 1.06
RSI 59.34
Cílová cena analytiků 6
Známka akcie (dle analytiků) N/A
Insider ownership 7.81 %
Institutional ownership 60.71 %
Počet akcií 48.472M
Procento shortovaných akcií 1.58 %
Short ratio 7.83 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1980
Země United States

Finanční výsledky akcie ENZ

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$76.021$81.17$101.013$105.086$102.773$97.599
Cost Of Goods Sold$52.251$57.922$60.385$59.478$57.19$54.772
Gross Profit$23.77$23.248$40.628$45.608$45.583$42.827
Research And Development Expenses$4.448$3.175$3.21$2.928$3.524$3.35
SG&A Expenses$42.96$44.265$44.455$44.149$43.741$41.069
Other Operating Income Or Expenses$-6.729$25.925$-5.127$-1.679$48.53$0.386
Operating Expenses$106.388$79.437$113.177$108.234$55.925$98.805
Operating Income$-30.367$1.733$-12.164$-3.148$46.848$-1.206
Total Non-Operating Income/Expense$1.847$0.756$0.746$0.644$-0.488$-1.086
Pre-Tax Income$-28.52$2.489$-11.418$-2.504$46.36$-2.292
Income Taxes--$-1.097-$1.074$-0.007
Income After Taxes$-28.52$2.489$-10.321$-2.504$45.286$-2.285
Other Income------
Income From Continuous Operations$-28.52$2.489$-10.321$-2.504$45.286$-2.285
Income From Discontinued Operations------
Net Income$-28.52$2.489$-10.321$-2.504$45.286$-2.285
EBITDA$-27.587$4.769$-9.034$0.45$50.688$2.583
EBIT$-30.367$1.733$-12.164$-3.148$46.848$-1.206
Basic Shares Outstanding484747464645
Shares Outstanding484747464745
Basic EPS$-0.60$0.05$-0.22$-0.05$0.98$-0.05
EPS - Earnings Per Share$-0.60$0.05$-0.22$-0.05$0.97$-0.05
# 2020 2019 2018 2017 2016 2015
Current Ratio2.09645.0884.12175.00194.44371.9403
Long-term Debt / Capital0.07130.0463----
Debt/Equity Ratio0.19670.0486--0.01740.0707
Gross Margin31.267728.641140.220643.400644.353143.8806
Operating Margin-39.94552.135-12.042-2.995645.584-1.2357
EBIT Margin-39.94552.135-12.042-2.995645.584-1.2357
EBITDA Margin-36.28875.8753-8.94340.428249.32042.6466
Pre-Tax Profit Margin-37.5163.0664-11.3035-2.382845.1091-2.3484
Net Profit Margin-37.5163.0664-10.2175-2.382844.0641-2.3412
Asset Turnover0.67550.76120.99360.9760.91911.427
Inventory Turnover Ratio6.71267.38618.29698.44028.2047.4056
Receiveable Turnover8.31657.55917.68346.92277.04315.2028
Days Sales In Receivables43.888748.28647.505352.725451.823770.1548
ROE - Return On Equity-48.85152.8932-12.723-2.817550.5684-5.3631
Return On Tangible Equity-56.59743.2098-14.3781-3.188858.2982-7.8796
ROA - Return On Assets-25.34262.334-10.1525-2.325740.4987-3.3409
ROI - Return On Investment-45.36632.7592-12.723-2.817550.5684-5.3631
Book Value Per Share1.21891.80891.71931.9111.93550.925
Operating Cash Flow Per Share-0.46140.1594-0.0538-1.14441.2216-0.0417
Free Cash Flow Per Share-0.33580.0285-0.0562-1.14941.2281-0.0613